Cargando…
Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice
BACKGROUND/AIMS: The persistent existence of pathological cardiac remodeling, resulting from aortic stenosis, is related to poor clinical prognosis after successful transcatheter aortic valve replacement (TAVR). Sacubitril/valsartan (Sac/Val), comprising an angiotensin receptor blocker and a neprily...
Autores principales: | Li, Xueling, Zhu, Qin, Wang, Qingcheng, Zhang, Qinggang, Zheng, Yaru, Wang, Lihong, Jin, Qinyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497317/ https://www.ncbi.nlm.nih.gov/pubmed/32444995 http://dx.doi.org/10.1007/s10557-020-06995-x |
Ejemplares similares
-
Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts
por: Li, Xiaofei, et al.
Publicado: (2021) -
Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
por: Nordén, Einar Sjaastad, et al.
Publicado: (2021) -
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022) -
Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023) -
Sacubitril/Valsartan Improves Progression of Early Diabetic Nephropathy in Rats Through Inhibition of NLRP3 Inflammasome Pathway
por: Pan, Yan, et al.
Publicado: (2022)